ARCHIVES

FDA Approves NDA For Mylan’s Paclitaxel For Ovarian And Breast Cancer Treatment.

This article is from The Cancer Letter archive.

Vol. 27 No. 30 | July 27, 2001

Download PDF Visit The Full Archive

Related Articles

“Imaginary Treatments,” “Wonderful Cures”

June 6, 1997

Advanced Radiation Technique Reduced Swallowing Problems

May 28, 2010

Alimta/Cisplatin Chemotherapy Increased Overall Survival

June 29, 2012

Three Genetics Pioneers Win Nobel Prize

October 11, 2002

Bush Proposes 16 Percent Increase For NIH, To Complete Budget Doubling.

February 1, 2002

Emory Stops Patient Accrual After Discovering Problems In Management

June 26, 2009